Hepatitis B in Ukraine: What are the Remaining Challenges? - Maryna Sukach, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

HIV/HCV Co-Infection: Influence on Risk for Cancer and Cardiovascular Events - Ligita Jancoriene, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Vaccinations for HIV Patients: Which Vaccinations, When, and How? - Carolynne Schwarze Zander, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Challenging TB Case: Clinical, Virological and Pharmacological Considerations - Jonathan Schapiro, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Management of TB and HIV Infection - Daria Podlekareva, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Switching to Second-Line HIV Therapy - Pavel Khaykin, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Integrated Testing for HIV, Hepatitis and STIs - Dorthe Raben, MSc

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

PrEP and STI Testing in CEE: What are the Barriers, What Works? - Milosz Parczewski, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Management of HIV/HCV Co-Infection in Young Women - Ekaterina Boeva, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

EECA: Are We Lagging Behind? - Sergey Golovin

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Access to Key Populations - Mojca Maticic, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Access to Quality-Assured (WHO Prequalified) Generic Medicines in the Region - Liudmyla Maistat

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Epidemiology of Viral Hepatitis Infection and Treatment in the CEE Countries - Milosz Parczewski, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Feasibility and Acceptability of HCV Self-Testing - Elena Ivanova, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Epidemiology of HIV Infection and Treatment in the CEE Countries - Anca Streinu-Cercel, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

EECA: Are we Lagging Behind? - Sergey Golovin

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Epidemiology of Viral Hepatitis Infection and Treatment in CEE Countries - Miłosz Parczewski, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Access to Key Populations - Mojca Maticic, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Access to Quality Assured (WHO Prequalified) Generic Medicines in the Region - Liudmyla Maista

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

07_Boeva

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

The Prevalence of Mutations of the Hepatitis C Virus, Associated with Drug Resistance to Inhibitors of Protein NS5A Among Patients of the Republic of Belarus - Elena Gasich

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Virological Efficacy of First-Line Regimens, Resistance Profile and Factors Influencing Adherence to ART in Clinical Practice in Ukraine - Tetiana Kyrychenko

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

Switching to Second Line HIV Therapy - Pavel Khaykin, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019

PrEP and STI Testing in CEE: What are the Barriers, What Works? - Miłosz Parczewski, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2019